カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界の皮膚糸状菌症治療薬市場予測2023-2029：Rx、OTC

【英語タイトル】Dermatophytosis Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8458）・商品コード：MMG23LY8458
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：77
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の皮膚糸状菌症治療薬市場規模と予測を収録しています。・世界の皮膚糸状菌症治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の皮膚糸状菌症治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の皮膚糸状菌症治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「Rx」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

皮膚糸状菌症治療薬のグローバル主要企業は、Novartis、 Pfizer、 Sanofi-Aventis、 Merck、 Enzon Pharmaceuticals、 Bayer、 Astellas Pharma、 GSK、 Abbottなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、皮膚糸状菌症治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の皮膚糸状菌症治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の皮膚糸状菌症治療薬市場：タイプ別市場シェア、2022年
・Rx、OTC

世界の皮膚糸状菌症治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の皮膚糸状菌症治療薬市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の皮膚糸状菌症治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の皮膚糸状菌症治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における皮膚糸状菌症治療薬のグローバル売上、2018年-2023年
・主要企業における皮膚糸状菌症治療薬のグローバル売上シェア、2022年
・主要企業における皮膚糸状菌症治療薬のグローバル販売量、2018年-2023年
・主要企業における皮膚糸状菌症治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Novartis、 Pfizer、 Sanofi-Aventis、 Merck、 Enzon Pharmaceuticals、 Bayer、 Astellas Pharma、 GSK、 Abbott

*************************************************************

・調査・分析レポートの概要
皮膚糸状菌症治療薬市場の定義
市場セグメント
世界の皮膚糸状菌症治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の皮膚糸状菌症治療薬市場規模
世界の皮膚糸状菌症治療薬市場規模：2022年 VS 2029年
世界の皮膚糸状菌症治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの皮膚糸状菌症治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の皮膚糸状菌症治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：Rx、OTC
皮膚糸状菌症治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
皮膚糸状菌症治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別皮膚糸状菌症治療薬市場規模 2022年と2029年
地域別皮膚糸状菌症治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Novartis、 Pfizer、 Sanofi-Aventis、 Merck、 Enzon Pharmaceuticals、 Bayer、 Astellas Pharma、 GSK、 Abbott
...

Ringworm on the skin like athlete’s foot (tinea pedis) and jock itch (tinea cruris) can usually be treated with non-prescription antifungal creams, lotions, or powders applied to the skin for 2 to 4 weeks.
This report aims to provide a comprehensive presentation of the global market for Dermatophytosis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatophytosis Drugs. This report contains market size and forecasts of Dermatophytosis Drugs in global, including the following market information:
Global Dermatophytosis Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Dermatophytosis Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Dermatophytosis Drugs companies in 2022 (%)
The global Dermatophytosis Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Rx Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Dermatophytosis Drugs include Novartis, Pfizer, Sanofi-Aventis, Merck, Enzon Pharmaceuticals, Bayer, Astellas Pharma, GSK and Abbott, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dermatophytosis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dermatophytosis Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dermatophytosis Drugs Market Segment Percentages, by Type, 2022 (%)
Rx
OTC
Global Dermatophytosis Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dermatophytosis Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Other
Global Dermatophytosis Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Dermatophytosis Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dermatophytosis Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Dermatophytosis Drugs revenues share in global market, 2022 (%)
Key companies Dermatophytosis Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Dermatophytosis Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Pfizer
Sanofi-Aventis
Merck
Enzon Pharmaceuticals
Bayer
Astellas Pharma
GSK
Abbott
Outline of Major Chapters:
Chapter 1: Introduces the definition of Dermatophytosis Drugs, market overview.
Chapter 2: Global Dermatophytosis Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Dermatophytosis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dermatophytosis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Dermatophytosis Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Dermatophytosis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dermatophytosis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dermatophytosis Drugs Overall Market Size
2.1 Global Dermatophytosis Drugs Market Size: 2022 VS 2029
2.2 Global Dermatophytosis Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Dermatophytosis Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Dermatophytosis Drugs Players in Global Market
3.2 Top Global Dermatophytosis Drugs Companies Ranked by Revenue
3.3 Global Dermatophytosis Drugs Revenue by Companies
3.4 Global Dermatophytosis Drugs Sales by Companies
3.5 Global Dermatophytosis Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Dermatophytosis Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Dermatophytosis Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dermatophytosis Drugs Players in Global Market
3.8.1 List of Global Tier 1 Dermatophytosis Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Dermatophytosis Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Dermatophytosis Drugs Market Size Markets, 2022 & 2029
4.1.2 Rx
4.1.3 OTC
4.2 By Type – Global Dermatophytosis Drugs Revenue & Forecasts
4.2.1 By Type – Global Dermatophytosis Drugs Revenue, 2018-2023
4.2.2 By Type – Global Dermatophytosis Drugs Revenue, 2024-2029
4.2.3 By Type – Global Dermatophytosis Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Dermatophytosis Drugs Sales & Forecasts
4.3.1 By Type – Global Dermatophytosis Drugs Sales, 2018-2023
4.3.2 By Type – Global Dermatophytosis Drugs Sales, 2024-2029
4.3.3 By Type – Global Dermatophytosis Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Dermatophytosis Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Dermatophytosis Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Dermatophytosis Drugs Revenue & Forecasts
5.2.1 By Application – Global Dermatophytosis Drugs Revenue, 2018-2023
5.2.2 By Application – Global Dermatophytosis Drugs Revenue, 2024-2029
5.2.3 By Application – Global Dermatophytosis Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Dermatophytosis Drugs Sales & Forecasts
5.3.1 By Application – Global Dermatophytosis Drugs Sales, 2018-2023
5.3.2 By Application – Global Dermatophytosis Drugs Sales, 2024-2029
5.3.3 By Application – Global Dermatophytosis Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Dermatophytosis Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Dermatophytosis Drugs Market Size, 2022 & 2029
6.2 By Region – Global Dermatophytosis Drugs Revenue & Forecasts
6.2.1 By Region – Global Dermatophytosis Drugs Revenue, 2018-2023
6.2.2 By Region – Global Dermatophytosis Drugs Revenue, 2024-2029
6.2.3 By Region – Global Dermatophytosis Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Dermatophytosis Drugs Sales & Forecasts
6.3.1 By Region – Global Dermatophytosis Drugs Sales, 2018-2023
6.3.2 By Region – Global Dermatophytosis Drugs Sales, 2024-2029
6.3.3 By Region – Global Dermatophytosis Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Dermatophytosis Drugs Revenue, 2018-2029
6.4.2 By Country – North America Dermatophytosis Drugs Sales, 2018-2029
6.4.3 US Dermatophytosis Drugs Market Size, 2018-2029
6.4.4 Canada Dermatophytosis Drugs Market Size, 2018-2029
6.4.5 Mexico Dermatophytosis Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Dermatophytosis Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Dermatophytosis Drugs Sales, 2018-2029
6.5.3 Germany Dermatophytosis Drugs Market Size, 2018-2029
6.5.4 France Dermatophytosis Drugs Market Size, 2018-2029
6.5.5 U.K. Dermatophytosis Drugs Market Size, 2018-2029
6.5.6 Italy Dermatophytosis Drugs Market Size, 2018-2029
6.5.7 Russia Dermatophytosis Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Dermatophytosis Drugs Market Size, 2018-2029
6.5.9 Benelux Dermatophytosis Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Dermatophytosis Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Dermatophytosis Drugs Sales, 2018-2029
6.6.3 China Dermatophytosis Drugs Market Size, 2018-2029
6.6.4 Japan Dermatophytosis Drugs Market Size, 2018-2029
6.6.5 South Korea Dermatophytosis Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Dermatophytosis Drugs Market Size, 2018-2029
6.6.7 India Dermatophytosis Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Dermatophytosis Drugs Revenue, 2018-2029
6.7.2 By Country – South America Dermatophytosis Drugs Sales, 2018-2029
6.7.3 Brazil Dermatophytosis Drugs Market Size, 2018-2029
6.7.4 Argentina Dermatophytosis Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Dermatophytosis Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Dermatophytosis Drugs Sales, 2018-2029
6.8.3 Turkey Dermatophytosis Drugs Market Size, 2018-2029
6.8.4 Israel Dermatophytosis Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Dermatophytosis Drugs Market Size, 2018-2029
6.8.6 UAE Dermatophytosis Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Dermatophytosis Drugs Major Product Offerings
7.1.4 Novartis Dermatophytosis Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Dermatophytosis Drugs Major Product Offerings
7.2.4 Pfizer Dermatophytosis Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Sanofi-Aventis
7.3.1 Sanofi-Aventis Company Summary
7.3.2 Sanofi-Aventis Business Overview
7.3.3 Sanofi-Aventis Dermatophytosis Drugs Major Product Offerings
7.3.4 Sanofi-Aventis Dermatophytosis Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi-Aventis Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Dermatophytosis Drugs Major Product Offerings
7.4.4 Merck Dermatophytosis Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Enzon Pharmaceuticals
7.5.1 Enzon Pharmaceuticals Company Summary
7.5.2 Enzon Pharmaceuticals Business Overview
7.5.3 Enzon Pharmaceuticals Dermatophytosis Drugs Major Product Offerings
7.5.4 Enzon Pharmaceuticals Dermatophytosis Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Enzon Pharmaceuticals Key News & Latest Developments
7.6 Bayer
7.6.1 Bayer Company Summary
7.6.2 Bayer Business Overview
7.6.3 Bayer Dermatophytosis Drugs Major Product Offerings
7.6.4 Bayer Dermatophytosis Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Bayer Key News & Latest Developments
7.7 Astellas Pharma
7.7.1 Astellas Pharma Company Summary
7.7.2 Astellas Pharma Business Overview
7.7.3 Astellas Pharma Dermatophytosis Drugs Major Product Offerings
7.7.4 Astellas Pharma Dermatophytosis Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Astellas Pharma Key News & Latest Developments
7.8 GSK
7.8.1 GSK Company Summary
7.8.2 GSK Business Overview
7.8.3 GSK Dermatophytosis Drugs Major Product Offerings
7.8.4 GSK Dermatophytosis Drugs Sales and Revenue in Global (2018-2023)
7.8.5 GSK Key News & Latest Developments
7.9 Abbott
7.9.1 Abbott Company Summary
7.9.2 Abbott Business Overview
7.9.3 Abbott Dermatophytosis Drugs Major Product Offerings
7.9.4 Abbott Dermatophytosis Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Abbott Key News & Latest Developments
8 Global Dermatophytosis Drugs Production Capacity, Analysis
8.1 Global Dermatophytosis Drugs Production Capacity, 2018-2029
8.2 Dermatophytosis Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Dermatophytosis Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Dermatophytosis Drugs Supply Chain Analysis
10.1 Dermatophytosis Drugs Industry Value Chain
10.2 Dermatophytosis Drugs Upstream Market
10.3 Dermatophytosis Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Dermatophytosis Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Dermatophytosis Drugs in Global Market
Table 2. Top Dermatophytosis Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Dermatophytosis Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Dermatophytosis Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Dermatophytosis Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Dermatophytosis Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Dermatophytosis Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Dermatophytosis Drugs Product Type
Table 9. List of Global Tier 1 Dermatophytosis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dermatophytosis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Dermatophytosis Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Dermatophytosis Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Dermatophytosis Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Dermatophytosis Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Dermatophytosis Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Dermatophytosis Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Dermatophytosis Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Dermatophytosis Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Dermatophytosis Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Dermatophytosis Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Dermatophytosis Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Dermatophytosis Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Dermatophytosis Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Dermatophytosis Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Dermatophytosis Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Dermatophytosis Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Dermatophytosis Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Dermatophytosis Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Dermatophytosis Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Dermatophytosis Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Dermatophytosis Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Dermatophytosis Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Dermatophytosis Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Dermatophytosis Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Dermatophytosis Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Dermatophytosis Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Dermatophytosis Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Dermatophytosis Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Dermatophytosis Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Dermatophytosis Drugs Sales, (K Units), 2024-2029
Table 46. Novartis Company Summary
Table 47. Novartis Dermatophytosis Drugs Product Offerings
Table 48. Novartis Dermatophytosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Dermatophytosis Drugs Product Offerings
Table 52. Pfizer Dermatophytosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Sanofi-Aventis Company Summary
Table 55. Sanofi-Aventis Dermatophytosis Drugs Product Offerings
Table 56. Sanofi-Aventis Dermatophytosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Sanofi-Aventis Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Dermatophytosis Drugs Product Offerings
Table 60. Merck Dermatophytosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Merck Key News & Latest Developments
Table 62. Enzon Pharmaceuticals Company Summary
Table 63. Enzon Pharmaceuticals Dermatophytosis Drugs Product Offerings
Table 64. Enzon Pharmaceuticals Dermatophytosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Enzon Pharmaceuticals Key News & Latest Developments
Table 66. Bayer Company Summary
Table 67. Bayer Dermatophytosis Drugs Product Offerings
Table 68. Bayer Dermatophytosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Bayer Key News & Latest Developments
Table 70. Astellas Pharma Company Summary
Table 71. Astellas Pharma Dermatophytosis Drugs Product Offerings
Table 72. Astellas Pharma Dermatophytosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Astellas Pharma Key News & Latest Developments
Table 74. GSK Company Summary
Table 75. GSK Dermatophytosis Drugs Product Offerings
Table 76. GSK Dermatophytosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. GSK Key News & Latest Developments
Table 78. Abbott Company Summary
Table 79. Abbott Dermatophytosis Drugs Product Offerings
Table 80. Abbott Dermatophytosis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Abbott Key News & Latest Developments
Table 82. Dermatophytosis Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global Dermatophytosis Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Dermatophytosis Drugs Production by Region, 2018-2023 (K Units)
Table 85. Global Dermatophytosis Drugs Production by Region, 2024-2029 (K Units)
Table 86. Dermatophytosis Drugs Market Opportunities & Trends in Global Market
Table 87. Dermatophytosis Drugs Market Drivers in Global Market
Table 88. Dermatophytosis Drugs Market Restraints in Global Market
Table 89. Dermatophytosis Drugs Raw Materials
Table 90. Dermatophytosis Drugs Raw Materials Suppliers in Global Market
Table 91. Typical Dermatophytosis Drugs Downstream
Table 92. Dermatophytosis Drugs Downstream Clients in Global Market
Table 93. Dermatophytosis Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Dermatophytosis Drugs Segment by Type in 2022
Figure 2. Dermatophytosis Drugs Segment by Application in 2022
Figure 3. Global Dermatophytosis Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Dermatophytosis Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Dermatophytosis Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Dermatophytosis Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Dermatophytosis Drugs Revenue in 2022
Figure 9. By Type - Global Dermatophytosis Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Dermatophytosis Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Dermatophytosis Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Dermatophytosis Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Dermatophytosis Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Dermatophytosis Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Dermatophytosis Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Dermatophytosis Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Dermatophytosis Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Dermatophytosis Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Dermatophytosis Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Dermatophytosis Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Dermatophytosis Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Dermatophytosis Drugs Sales Market Share, 2018-2029
Figure 23. US Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Dermatophytosis Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Dermatophytosis Drugs Sales Market Share, 2018-2029
Figure 28. Germany Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Dermatophytosis Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Dermatophytosis Drugs Sales Market Share, 2018-2029
Figure 37. China Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Dermatophytosis Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Dermatophytosis Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Dermatophytosis Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Dermatophytosis Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Dermatophytosis Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Dermatophytosis Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Dermatophytosis Drugs by Region, 2022 VS 2029
Figure 54. Dermatophytosis Drugs Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界の皮膚糸状菌症治療薬市場予測2023-2029：Rx、OTC] (コード：MMG23LY8458)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の皮膚糸状菌症治療薬市場予測2023-2029：Rx、OTC]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の前頭洞炎治療薬市場予測2023-2029：抗生物質、コルチコステロイド、鼻詰まり除去剤
  • 世界のCAR T細胞型薬剤市場予測2023-2029：CD19標的、BCMA標的
  • 世界の血液内科用医薬品市場予測2023-2029：OTC、Rx医薬品
  • 世界の整形外科用処方薬市場予測2023-2029：経口、局所
  • 世界の認知機能増進薬市場予測2023-2029：経口型、注射型

    • ◆H&Iグローバルリサーチのお客様（例）◆